Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.22

€1.22

-1.770%
-0.022
-1.770%
€3.60
 
16:42 / Tradegate WKN: A1XF0S / Symbol: AKBA / Name: Akebia / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Akebia

sharewise wants to provide you with the best news and tools for Akebia, so we directly link to the best financial data sources.

News

Akebia Therapeutics Surges on FDA Approval for Anemia Treatment: https://www.marketbeat.com/logos/articles/med_20240331142316_untitledchart-akd.jpg
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment

Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia management for patients with CKD. The